Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
The de-extinction startup is looking to double or triple its previous valuation, according to the report.
Search fresh public links, source activity, and ready-to-use post angles for Biotech Beast.
Fresh curated links around Biotech Beast are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
The de-extinction startup is looking to double or triple its previous valuation, according to the report.
Colossal Biosciences claims to have brought back the dire wolf, and is now hard at work on its quest to resurrect several other species, including the woolly mammoth and the moa, a...
Led by serial biotech entrepreneur Greg Verdine, the startup mined fungi genomes to find a safer alternative to the drugs widely used to prevent the body from rejecting transplante...
Innovation-driven, Steady Advancement
The CRAB Lab builds on a long-standing partnership between UMD and NIST through IBBR, which will serve as the physical home for instrumentation, facilities, and scientific expertis...
A bioreactor designed to test biosensors that measure multiple parameters in real time is being developed as a simple, budget-friendly bioreactor for high schools and colleges to h...
Prospect of patents expiring on lucrative drugs prompts drugmakers to hunt for next blockbuster medicines
Ohio’s $30M training initiative aims to scale talent pipelines and power life sciences growth statewide.
Southeast Asia’s startup story is usually told through ride-hailing, fintech, and e-commerce. But a quieter, stranger, and potentially more consequential sector is taking shape in...
The overwhelming demand for GLP-1 weight loss drugs has reshaped the drug market, empowering consumers to take charge of their own health and removing barriers between their wallet...
Saudi Arabia is pairing gene editing breakthroughs with new biomanufacturing capacity, from CRISPR oncology therapies to CDMOs like Lifera, as it builds a full biotech pipeline. Th...
Generating biomanufacturing-relevant data on protein production in a large-scale, AI-enabled database is still rare. When commercialized, it may substantially improve development t...
Not only is the XBI continuing to hover around a historic high, but drug companies can’t seem to get enough of both large IPOs and big-ticket M&A.
The world of biotech is showing strong signs of growth and clinical impact while also experiencing new challenges. The explosion of AI is reshaping areas from drug discovery and pr...
American biotechnology hubs like Boston, Seattle, and San Diego are starting to wake up again. But will they be able to learn from the lessons of the recent past? The post Biopharm...
Boston. San Francisco. Beijing? The global biotech industry has long been concentrated in a handful of cities. But which emerging hubs could become dominant forces in biotech in th...
How can biotechs be investor ready? Key takeaways from BIO International and DIA China 2026.
Discover how small adjustments make your microbial process more robust and reproducible during scale-up and technology transfer. The post Could your microbial process be stronger?...
To produce stable cell lines for monoclonal antibody production, manufacturers typically use the piggyBac transposon system. For larger, multi-specific antibodies that have payload...
Optimized process delivered a 10-fold improvement in productivity, significantly improving the estimated economics of future commercial-scale manufacturing.Estimated manufacturing...
The four-year-old firm's latest fund is 60% larger than its second vehicle announced 18 months ago.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.